News | December 14, 2006

SVG Embolic Device Now Cleared for Carotids

The embolic protection system Boston Scientific Corp. originally designed for coronary saphenous vein graft interventions has received FDA clearance for use in carotid artery stenting procedures. FilterWire EZ was approved in August 2004 for the SVG indication and, the company says, it is the current market-leading embolic protection device for carotid stenting outside the U.S.

The system is designed to efficiently capture plaque and other embolic material that may dislodge during stent implantation and prevent it from traveling into the microvasculature where it could pose an increased risk for stroke or heart attack. With a simplified, one-size filter for vessels 3.5 to 5.5mm in length, FilterWire EZ offers easy preparation, delivery and retrieval.

The FilterWire EZ System was evaluated in the CABERNET Trial in conjunction with the recently approved NexStent Carotid Stent and Monorail Delivery System. The new carotid indication allows U.S. physicians to use the device to treat patients with carotid artery disease who are at high risk for surgery.

For more information, visit www.bostonscientific.com.

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
FDA clears Claret Medical Sentinel embolic protection device for TAVR
Feature | Heart Valve Technology| June 09, 2017
June 5, 2017 – The U.S.
Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Artery Disease (PAD)| May 17, 2017
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon...
PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices| April 11, 2017
Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an investigational device...
Cardiogard embolic protection system for surgical valve reaplacement

The CardioGard embolic protection system for surgical aortic valve replacement.

Feature | Embolic Protection Devices| March 22, 2017
March 22, 2017 — Two U.S.
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
Videos | Heart Valve Technology| November 08, 2016
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage
Overlay Init